Newstral
Stephen Hoge
- Moderna Announces Update on Investigational RSV Vaccinenewsobserver.com
- Moderna Stock Soars After Cancer Vaccine’s Strong Test ResultsForbes
- Moderna poised to seek flu shot approval after trial resultspressherald.com
- Moderna poised to seek flu shot approval after trial results - Wed, 13 Sep 2023 PSTsyndication.washingtonpost.com
- TModerna says COVID vaccine offers protection against BA.2.86 ‘Pirola’ variantthehill.com
- MModerna says new Covid vaccine efficient towards BA.2.86 variantmvtelegraph.com
- Moderna’s Updated Covid Vaccine Is Effective Against Pirola Variant—As Concern Over New Strain GrowsForbes
- MNew vaccines will possible defend in opposition to Eris variantmvtelegraph.com
- Fall COVID shots will boost protection against latest subvariants, Moderna saysArs Technica
- MOutcomes from Moderna (MRNA) Q1 2023mvtelegraph.com
- Moderna: Moderna tries to show it’s not a ‘one trick pony’Financial Times
- Moderna paid the US more than enough for COVID shot partnership, executive sayskentucky.com
- Moderna eyes bird flu, monkeypox shotsnwaonline.com
- Moderna eyes testing mpox, bird flu vaccines in humans this year - Mon, 06 Mar 2023 PSTsyndication.washingtonpost.com
- MModerna (MRNA) This autumn Outcomes 2022mvtelegraph.com
- MModerna’s stock slides as earnings fall short of estimates amid steep decline in COVID-vaccine sales4 min readmarketwatch.com
- TStocks Extend Slide, Moderna, DraftKings, Deere, Applied Materials In Focus - Five Things To Knowthestreet.com
- Moderna says RSV vaccine 84% effective at preventing symptoms in older adultsCBC
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.